Rv0241c (HtdX) is a putative (3R)-hydroxyacyl-CoA dehydratase of Mycobacterium tuberculosis. The htdX gene belongs to a conserved operon and is expressed in mycobacteria in the presence of several fatty-acid synthase II drugs. To elucidate the structure of HtdX, the protein was cloned, overexpressed, purified to homogeneity and crystallized. The protein was crystallized from two conditions: (i) 3 M sodium chloride, 0.1 M Na HEPES pH 8.0 and (ii) 2.5 M sodium chloride, 0.1 M Tris-HCl pH 8.5. A complete diffraction data set was collected from crystals from both conditions. The crystal from the first condition diffracted to 2.3 Å resolution and belonged to space group I4 1 , with unit-cell parameters a = b = 61.51, c = 143.81 Å . Crystals from the second condition diffracted to 3.
Introduction
Tuberculosis caused by Mycobacterium tuberculosis remains a major health problem. It infects millions of people every year and is the second leading cause of death worldwide (World Health Organization, 2012) . The appearance of new multidrug-resistant TB (MDR-TB) and extremely multidrug-resistant TB (XDR-TB) has made this problem more complex (World Health Organization, 2010) . Hence, new drugs are necessary in order to combat the disease.
M. tuberculosis possesses an extremely lipid-rich and highly impermeable cell wall. The key components of this outer envelope are mycolic acids. Mycolic acids are the product of two fatty-acid synthase systems present in mycobacteria: mammalian-type fatty-acid synthase I (FAS-I) (Smith et al., 2003) and bacterial-type fatty-acid synthase II (FAS-II) (Takayama et al., 2005; White et al., 2005) . FAS-I consists of a single enzyme containing all of the catalytic domains required for the fatty-acid elongation cycle (Boehringer et al., 2013; Ciccarelli et al., 2013) . On the other hand, the FAS-II pathway employs the discrete enzymes mtFabD (Kremer et al., 2001) , KasA/ KasB (Gao et al., 2003; Schaeffer et al., 2001) , MabA (Marrakchi et al., 2002) , HadABC (Sacco et al., 2007) , InhA (Dessen et al., 1995) and AcpM (Wong et al., 2002) .
Classically, the dehydration step of the FAS-II system is carried out by either a (3R)-hydroxyacyl-ACP dehydratase (FabZ) or a (3R)hydroxyacyl-ACP dehydratase/isomerase (FabA). However, in mycobacteria there is no single FabZ or FabA protein in the FAS-II pathway; instead, a gene cluster HadABC consisting of HadA (Rv0635), HadB (Rv0636) and HadC (Rv0637) is required for the dehydratase step (Sacco et al., 2007) . Functional analysis based on BLAST results shows that in addition to HadABC the mycobacterial genome encodes genes which can perform a dehydration step. These include Rv0216, Rv0241c, Rv0504c, Rv2499c, Rv3389c, Rv3538 and Rv3542c (Castell et al., 2005; Takayama et al., 2005) . Among these, Rv0241c or HtdX was first identified in the mycobacterial membraneassociated fraction (Gu et al., 2003) and was eventually identified in the mRNA pool when cultured in the presence of several FAS-II drugs (Boshoff et al., 2004) . Recent work on heterologous expression of HtdX has shown that it can participate in the yeast mitochondrial fatty-acid synthetic pathway ) but can only restore the dehydratase activity in Escherichia coli (Sacco et al., 2010) . This R-specific -hydroxyacyl-CoA dehydratase is hypothesized to be involved in an alternative or intermediate fatty-acid synthetic pathway required for antibiotic resistance (Kikuchi & Kusaka, 1983; Boshoff et al., 2004; Sacco et al., 2010) . Based on the genomic arrangement in Mycobacteria and STRING functional protein association networks, a putative fatty-acid metabolizing operon was identified showing two genes Rv0241c (HtdX) and Rv0242c (FabG4) could be involved in the pathway (Gurvitz, 2009; Dutta et al., 2011) . FabG4, which has been characterized recently, is an NADH-dependent -ketoacyl CoA reductase (Dutta et al., 2011 (Dutta et al., , 2013 . To elucidate the function of Rv0241c (HtdX), we attempted to determine the structure of HtdX. This communication reports the cloning strategy, purification, crystallization, data collection and initial diffraction data analysis of Rv0241c.
Materials and methods

Cloning
The sequence corresponding to the ORF of Rv0241c (UniProt ID O53664) was amplified by polymerase chain reaction (PCR) using M. tuberculosis H37Rv genomic DNA as template with the primers 5 0 -CAGGGATCCGTGACTCAACCCAGCGGCCTGAAG-3 0 (forward primer with BamHI site) and 5 0 -GTGGAAGCTTCTATA-GACCCCGCACGGTAGCGG-3 0 (reverse primer with HindIII site).
The amplified PCR product was purified by a Qiagen purification kit and cloned into the pQE30 expression vector (Qiagen, USA) which contains six consecutive His codons at the N-terminus of the multiple cloning site (MCS). The recombinant DNA was transformed into E. coli SG13009 (pREP4) cells and subsequently selected on ampicillin/ kanamycin plates. The positive clones were verified by DNA sequencing. This construct however produced insoluble recombinant protein.
To produce soluble protein. we first predicted the secondary structure of HtdX using PSIpred (Jones, 1999) and found that a long N-terminal region (1-25) might not have any rigid secondary structure. Owing to the long unstructured region there is a chance of misfolding when a large amount of full-length protein is expressed in E. coli. For this, we designed an N-terminal 28 residues truncated construct using the primers 5 0 -CAGGGATCCAACCGGACGGT-GACCGTC-3 0 (forward primer with BamHI site) and 5 0 -GTGGAAGCTTCTATAGACCCCGCACGGTAGCGG-3 0 (reverse primer with HindIII site) and followed the previous protocol for cloning and transformation. The resulting recombinant protein HtdX 29-280 was expressed in the soluble fraction. The resulting protein contains Gly and Ser residues between the hexahistidine tag and HtdX 29-280 owing to the BamHI restriction site which was used for crystallization.
Overexpression and purification
The positive clone harbouring the desired construct of HtdX (HtdX 29-280 ) was grown in Luria broth supplemented with 100 mg ml À1 ampicillin and 25 mg ml À1 kanamycin at 310 K for 3 h, after which the OD 600 reached 0.6, induced with 100 mM IPTG and grown for a further 16 h at 288 K in order to maximize the protein yield. The cells from a 4 l culture were harvested and resuspended in buffer A (10 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 5% glycerol) containing 0.1 mM each of leupeptin, pepstatin and aprotinin, and 0.02 mM phenylmethylsulfonyl fluoride (PMSF). The suspension was lysed by ultrasonication on ice and the lysate was centrifuged at 14 000 rev min À1 for 40 min. The supernatant was loaded onto Ni-Sepharose High Performance affinity matrix (GE Healthcare Biosciences) pre-equilibrated with buffer A. The column was then washed extensively with buffer A followed by buffer B (10 mM Tris-HCl pH 8.0, 300 mM NaCl, 50 mM imidazole, 5% glycerol) to remove nonspecifically bound contaminants. The protein was finally eluted with buffer C (10 mM Tris-HCl pH 8.0, 300 mM NaCl, 300 mM imidazole, 5% glycerol). The eluted protein was subjected to size-exclusion chromatography using Superdex 200 prepgrade matrix in a 16/70C column (GE Healthcare Biosciences) on an Ä KTAprime Plus system (GE Healthcare Biosciences) equilibrated with buffer D (10 mM Tris-HCl pH 8.0, 200 mM NaCl, 10 mM MgCl 2 , 5% glycerol). Fractions of 2 ml were collected at a flow rate of 1 ml min À1 . The fractions containing the desired protein were pooled together. The protein concentration was estimated by the method of Bradford (1976) and the purity was verified by 12% SDS-PAGE.
Crystallization
The purified protein was concentrated to 15 mg ml À1 in buffer D using a 10 kDa cutoff Vivaspin 20 concentrator (GE Healthcare). Preliminary screening for initial crystallization conditions was performed by the sitting-drop vapour-diffusion method using Crystal Screen and Crystal Screen 2 (Hampton Research, USA) at 298 K by mixing 2 ml droplets of concentrated protein solution with an equal volume of reservoir solution in a 96-well Corning treated flat-bottom plate (Corning, New York, USA) and equilibrated against 100 ml reservoir solution. Preliminary crystals were obtained from the condition 4.3 M sodium chloride, 0.1 M Na HEPES pH 7.5, which was further fine screened around the NaCl concentration and the buffer composition (pH range 7-9). Crystals of good diffraction quality appeared in about 4 d from two conditions: (i) 3 M sodium chloride, 0.1 M Na HEPES pH 8.0 ( Fig. 1a) and (ii) 2.5 M sodium chloride, 0.1 M Tris-HCl pH 8.5 (Fig. 1b) . A total of 3 mg protein was obtained from 4 l culture.
Data collection and processing
Prior to data collection, the crystals from both conditions were quick-soaked in a cryoprotectant solution containing 5%(v/v) glycerol in corresponding well solutions and flash-cooled in a nitrogen stream at 93 K. X-ray diffraction data were collected on an in-house Rigaku R-AXIS IV ++ image-plate detector using Cu K X-rays generated by a Rigaku MicroMax HF007 rotating-anode generator. The crystal-to-detector distance was kept at 140 mm and the crystal was rotated through a total of 360 with 1 rotation per frame. The crystal from condition (i) diffracted to a resolution of 2.3 Å . A total of 360 images were collected and data were processed using XDS (Kabsch, 1993) and scaled with SCALA (Evans, 2006) in space group I4 with a resulting overall R r.i.m. value of 9.9%. Similarly, images were collected for the crystal from condition (ii) which diffracted to a resolution of 3.1 Å . Images were processed as above in space group P422 with a resulting overall R r.i.m. value of 17.6%. Screw axes were determined using POINTLESS (Evans, 2006) from the CCP4 interface (Winn et al., 2011) . The final statistics of data collection and processing are given in Table 1 .
Results and discussion
HtdX, a putative (3R)-hydroxyacyl-CoA dehydratase of M. tuberculosis, was successfully cloned and overexpressed in E. coli SG13009 cells. The N-terminally truncated protein (HtdX 29-280 ) was purified to homogeneity with an N-terminal His 6 tag. The molecular weight of HtdX was predicted to be 28 kDa by analysing its sequence and was confirmed by 12% SDS-PAGE. The protein was crystallized in two conditions: (i) 3 M sodium chloride, 0.1 M Na HEPES pH 8.0 and (ii) 2.5 M sodium chloride, 0.1 M Tris-HCl pH 8.5. A crystal from the first condition diffracted to a resolution of 2.3 Å ( Fig. 2a) and diffraction data were processed in space group I4 1 , whereas a crystal from the second condition diffracted to a resolution of 3.1 Å (Fig. 2b ) and data were processed in space group P422 with the most probable screw axes suggested by POINTLESS to be P4 1 2 1 2/P4 3 2 1 2. Matthews coefficients for the I4 1 and P4 1 2 1 2/P4 3 2 1 2 crystals were determined to be 2.43 and 2.55 Å 3 Da À1 , respectively, suggesting a single molecule in the asymmetric unit (Matthews, 1968) . Although HtdX and FabZs catalyze similar reactions, they show less than 10% sequence identity. Sequence prediction indicates that HtdX has a double hot-dog fold unlike FabZ (Leesong et al., 1996) . HtdX shares highest sequence identity (52%) with the dehydratase domain of mycobacterial 
Figure 2
Diffraction images collected from crystals from (a) condition (i) and (b) condition (ii). For each frame, the oscillation width and the exposure time were 1 and 3 min, respectively. fatty-acid synthase (PDB entry 3zen; Boehringer et al., 2013) with low query coverage (15% sequence overlap). HtdX also shows homology with MaoC-like dehydratases and eukaryotic peroxisomal multifunctional dehydrogenase and hydratase 2 ( Table 2 ). Our initial attempt to solve the structure using molecular replacement employed the generation of several HtdX models using MODELLER (Sali & Blundell, 1993) . Protein structures used as templates are listed in Table 2 . However, molecular replacement failed, yielding solutions with low correlation coefficients and high R factors (60%). We assume that the molecular replacement did not work because either the sequence identity or the query coverage is compromised. Currently, preparations of heavy-atom derivatives are under way to obtain phase information either by SIRAS/MIRAS or SAD/MAD.
